Speaker(s): 

Arjun Pandya, MD, Resident, Geisinger - has nothing to disclose.

Michael Woodfin, MD, Resident, Geisinger- has nothing to disclose.

Elizabeth Conrad, MD, Resident, Geisinger- has nothing to disclose.

J. Clayton Curry, MD, Resident, Geisinger- has nothing to disclose

David Shafique, MD, Resident, Geisinger- has nothing to disclose.

Alison Varano, MD, Resident, Geisinger- has nothing to disclose.

Moderator(s): 

Eric Hossler, MD, Staff Member, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Improve clinicopathologic correlation.
• Incorporate new technology into practice.
• Review the prevalence of skin cancer in patients with Lynch Syndrome.
• Identify common dermatological manifestations of infectious disease that may be encountered on a medical mission trip.
• Identify relationships between cutaneous manifestations and cardiac disease.
• Identify the classification, behavior and management of keratoacanthoma, leading to more informed clinical decision making.
• Describe the evidence supporting current medical and surgical treatments available for hidradenitis suppurative.
• Recognize occupational exposure to the flight environment and its impact on skin cancer risk.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Eric Hossler, MD and Ashley Hubal, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None